Synthetic lethality-mediated precision oncology via the tumor transcriptome

Overview of attention for article published in Cell, April 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

So far, Altmetric has seen 4 news stories from 4 outlets.

TEL AVIV, Israel — Pangea Biomed, the biotech company behind ENLIGHT, the multi-cancer response predictor improving the…

Eytan Ruppin says one of his favorite talks to deliver is not about his research: “The title of my talk is ‘How not to build a…

NEW YORK – Pangea Biomed on Thursday said it would use $7 million in seed funding to use its transcriptomics-based Enlight…

Im Onko-Blog dieser Woche geht es um eine neue Therapie für das 3-fach negative Mammakarzinom und darum, ob Frauen mit…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.